hearX wins at the 2025 Global Health and Pharma Awards

Double triumph: hearX wins Top Global Health and Pharma Awards

October 22, 2025

Search for articles by category

The standard for hearing healthcare accessibility has been recognized and we are incredibly proud to announce a monumental double win at the 2025 Global Health and Pharma Awards. hearX has been named 'Best Digital Hearing Health Assessment Solutions Provider 2025’, and our flagship digital audiometer, hearTest, has secured the title of 'Best Digital Audiometry Solution 2025’.

This recognition is a powerful statement on the necessity for scalable, digital solutions and how we’re continually solving one of the most persistent, costly infrastructure challenges in global clinical healthcare.

Precision without borders: How hearTest sets the standard

For decades, accurate hearing testing was complex, expensive, and tethered to a soundproof booth. Our hearTest solution has played a significant role in revolutionizing this. As a clinically validated and FDA-registered, digital pure-tone audiometer, it delivers precision testing via a tablet and calibrated headphones, making boothless hearing assessments a reality anywhere.

The features that drive its success are built for efficiency and reliability. The system offers versatile testing modes—manual, smart manual, and self-test—along with offline functionality for reliable testing in any environment.

This operational efficiency, with a seamless data sync to hearX cloud—our specialized Health Information Management System (HIMS)—is the core of our digital ecosystem. It ensures centralized management of users, multiple devices, and hearing assessments across different locations, transforming the entire clinical workflow with real-time reporting.

Why these awards validate our mission

Winning these prestigious titles from the Global Health & Pharma Awards is a significant milestone. Now in its tenth year, this award celebrates businesses that are revolutionizing the Healthcare and Pharmaceutical Industries through excellence, resilience, and innovation.

For hearX to be recognized by this expert panel highlights that our unique approach—pairing clinical validity with scalable, real-world impact—is evolving the standard for patient care. We stand out by solving the challenges of timely hearing assessments, essential for patient safety and clinical outcomes in areas like ototoxicity monitoring. Our technology removes traditional logistical barriers, proving that high-quality care can be universally accessible.

Thank you to Global Health & Pharma Magazine. To our incredible partners, clients, and dedicated team—thank you for being essential in our mission to make hearing more accessible.


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
LXE Hearing lxehearing.com
hearX is proud to complete its SOC 2 Type II examination with the guidance of third-party audit firm A-LIGN.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data.

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | GDPR Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2025 hearX USA. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.